The average one-year price target for OptimizeRx (NasdaqCM:OPRX) has been revised to $24.82 / share. This is an increase of 24.79% from the prior estimate of $19.89 dated November 7, 2025.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $17.17 to a high of $33.60 / share. The average price target represents an increase of 63.50% from the latest reported closing price of $15.18 / share.
What is the Fund Sentiment?
There are 262 funds or institutions reporting positions in OptimizeRx. This is an increase of 21 owner(s) or 8.71% in the last quarter. Average portfolio weight of all funds dedicated to OPRX is 0.21%, an increase of 17.46%. Total shares owned by institutions increased in the last three months by 5.30% to 15,793K shares. 
The put/call ratio of OPRX is 0.65, indicating a bullish outlook.
What are Other Shareholders Doing?
Whetstone Capital Advisors holds 1,508K shares representing 8.09% ownership of the company. No change in the last quarter.
Royce & Associates holds 677K shares representing 3.63% ownership of the company. In its prior filing, the firm reported owning 791K shares , representing a decrease of 16.73%. The firm increased its portfolio allocation in OPRX by 26.38% over the last quarter.
Kennedy Capital Management holds 675K shares representing 3.62% ownership of the company. In its prior filing, the firm reported owning 472K shares , representing an increase of 30.00%. The firm increased its portfolio allocation in OPRX by 101.13% over the last quarter.
Blair William holds 591K shares representing 3.17% ownership of the company. In its prior filing, the firm reported owning 629K shares , representing a decrease of 6.39%. The firm increased its portfolio allocation in OPRX by 36.78% over the last quarter.
Rice Hall James & Associates holds 546K shares representing 2.93% ownership of the company. In its prior filing, the firm reported owning 608K shares , representing a decrease of 11.31%. The firm increased its portfolio allocation in OPRX by 38.15% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
